162 related articles for article (PubMed ID: 9641620)
21. Low temperature formation of calcium-deficient hydroxyapatite-PLA/PLGA composites.
Durucan C; Brown PW
J Biomed Mater Res; 2000 Sep; 51(4):717-25. PubMed ID: 10880121
[TBL] [Abstract][Full Text] [Related]
22. Preparation and physicochemical characterization of T-OA PLGA microspheres.
Fu J; Dong XX; Zeng ZP; Yin XB; Li FW; Ni J
Chin J Nat Med; 2017 Dec; 15(12):912-916. PubMed ID: 29329648
[TBL] [Abstract][Full Text] [Related]
23. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release.
Faisant N; Siepmann J; Benoit JP
Eur J Pharm Sci; 2002 May; 15(4):355-66. PubMed ID: 11988397
[TBL] [Abstract][Full Text] [Related]
24. Study of the initial stages of drug release from a degradable matrix of poly(d,l-lactide-co-glycolide).
Frank A; Kumar Rath S; Boey F; Venkatraman S
Biomaterials; 2004 Feb; 25(5):813-21. PubMed ID: 14609670
[TBL] [Abstract][Full Text] [Related]
25. Effect of divalent cations on pore formation and degradation of poly(D,L-lactide-co-glycolide).
Fredenberg S; Reslow M; Axelsson A
Pharm Dev Technol; 2007; 12(6):563-72. PubMed ID: 18161629
[TBL] [Abstract][Full Text] [Related]
26. Ketoprofen poly(lactide-co-glycolide) physical interaction.
Blasi P; Schoubben A; Giovagnoli S; Perioli L; Ricci M; Rossi C
AAPS PharmSciTech; 2007 May; 8(2):Article 37. PubMed ID: 17622115
[TBL] [Abstract][Full Text] [Related]
27. Assessment of biodegradable controlled release rod systems for pain relief applications.
Sendil D; Wise DL; Hasirci V
J Biomater Sci Polym Ed; 2002; 13(1):1-15. PubMed ID: 12003071
[TBL] [Abstract][Full Text] [Related]
28. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
[TBL] [Abstract][Full Text] [Related]
29. PLGA/Ag nanocomposites: in vitro degradation study and silver ion release.
Fortunati E; Latterini L; Rinaldi S; Kenny JM; Armentano I
J Mater Sci Mater Med; 2011 Dec; 22(12):2735-44. PubMed ID: 22002470
[TBL] [Abstract][Full Text] [Related]
30. Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis.
Zhang Y; Zale S; Sawyer L; Bernstein H
J Biomed Mater Res; 1997 Mar; 34(4):531-8. PubMed ID: 9054536
[TBL] [Abstract][Full Text] [Related]
31. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
32. PLGA-based nanoparticles as cancer drug delivery systems.
Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
[TBL] [Abstract][Full Text] [Related]
33. Effects of carbon nanotubes (CNTs) on the processing and in-vitro degradation of poly(DL-lactide-co-glycolide)/CNT films.
Armentano I; Dottori M; Puglia D; Kenny JM
J Mater Sci Mater Med; 2008 Jun; 19(6):2377-87. PubMed ID: 18158616
[TBL] [Abstract][Full Text] [Related]
34. Structure formation in injectable poly(lactide-co-glycolide) depots.
Wang L; Kleiner L; Venkatraman S
J Control Release; 2003 Jul; 90(3):345-54. PubMed ID: 12880701
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of nanoparticles containing an antihypertensive agent.
Leroueil-Le Verger M; Fluckiger L; Kim YI; Hoffman M; Maincent P
Eur J Pharm Biopharm; 1998 Sep; 46(2):137-43. PubMed ID: 9795032
[TBL] [Abstract][Full Text] [Related]
36. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.
Pollauf EJ; Berkland C; Kim KK; Pack DW
Int J Pharm; 2005 Sep; 301(1-2):294-303. PubMed ID: 16051452
[TBL] [Abstract][Full Text] [Related]
37. A local delivery system for fentanyl based on biodegradable poly(L-lactide-co-glycolide) oligomer.
Seo SA; Choi HS; Khang G; Rhee JM; Lee HB
Int J Pharm; 2002 Jun; 239(1-2):93-101. PubMed ID: 12052694
[TBL] [Abstract][Full Text] [Related]
38. A novel approach to prepare insulin-loaded poly(lactic-co-glycolic acid) microcapsules and the protein stability study.
Emami J; Hamishehkar H; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
J Pharm Sci; 2009 May; 98(5):1712-31. PubMed ID: 18855911
[TBL] [Abstract][Full Text] [Related]
39. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
[TBL] [Abstract][Full Text] [Related]
40. Formulation and evaluation of biodegradable nanoparticles for the oral delivery of fenretinide.
Graves RA; Ledet GA; Glotser EY; Mitchner DM; Bostanian LA; Mandal TK
Eur J Pharm Sci; 2015 Aug; 76():1-9. PubMed ID: 25933716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
